Related Experiment Videos

Expression and clinical significance of miR-223 in children with severe pneumonia

Min Wang1,2, Juan Wang1,2, Mengmeng Chen1,2

  • 1Clinical Laboratory, Children's Hospital Affiliated to Shandong University, 23976 Jing-Shi Road, Jinan, 250022, Shandong Province, PR China.

Scientific Reports
|July 2, 2026
PubMed

Insights

Plasma miR-223 is a promising biomarker for early detection of severe pneumonia in children. Combining miR-223 with routine markers significantly improves diagnostic accuracy and risk assessment for pediatric severe pneumonia.

Area of Science:

  • Pediatric Pulmonology
  • Molecular Diagnostics
  • Biomarker Discovery

Background:

  • Severe pneumonia is a leading cause of mortality in children under 5.
  • Current diagnostic markers lack specificity for early identification and severity assessment.
  • Novel biomarkers are crucial for timely and accurate diagnosis of pediatric severe pneumonia.

Purpose of the Study:

  • To investigate the diagnostic value of plasma miR-223 in pediatric severe pneumonia.
  • To evaluate the combined diagnostic performance of miR-223 with routine clinical indicators.
  • To assess the correlation of miR-223 with disease severity and prognosis.

Main Methods:

  • Quantitative real-time PCR for plasma miR-223 expression.
  • Collection of routine hematological, biochemical, and coagulation markers.
  • Statistical analyses including logistic regression and ROC curve analysis.

Main Results:

  • Plasma miR-223 levels were significantly elevated in children with severe pneumonia.
  • miR-223, neutrophil percentage, albumin, and fibrinogen were independent risk factors.
  • Combined model achieved an AUC of 0.99, outperforming single markers.
  • miR-223 upregulation was consistent across age subgroups.

Conclusions:

  • Plasma miR-223 is a reliable biomarker for pediatric severe pneumonia.
  • Combination with routine markers enhances diagnostic efficiency and risk evaluation.
  • miR-223 aids in disease stratification and prognosis assessment for children with severe pneumonia.

Related Concept Videos

Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...